The efficacy and safety of combined 0.01% atropine and orthokeratology for childhood myopia control: a 2-year randomized clinical trial

Ying Yuan, Yuqi Deng, Chengcheng Zhu, Xinting Liu, Wei Zhang, Bingru Zheng, Xinjie Mao, Xiao Yang, Bilian Ke · 2026

Read The efficacy and safety of combined 0.01% atropine and orthokeratology for childhood myopia control: a 2-year randomized clinical trial by Ying Yuan, Yuqi Deng, Chengcheng Zhu, Xinting Liu, Wei Zhang, Bingru Zheng, Xinjie Mao, Xiao Yang, Bilian Ke (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13171514.txt.

Description

Ying Yuan and co-authors test whether pairing weak atropine eye drops with overnight shaping lenses slows children's worsening eyesight better than the lenses alone, in a 2026 paper. Ninety-six children aged eight to twelve, all nearsighted, joined the two-year randomized trial at several centers. Half wore the overnight lenses, which flatten the cornea during sleep, plus a nightly drop of 0.01 percent atropine. The other half wore the lenses with a dummy drop.

Over two years, eyes in the combined group lengthened by 0.33 millimeters against 0.43 in the lens-only group, a real slowing, since eye lengthening drives myopia. The gain was clearest in younger children and in those starting with milder prescriptions. Tear film and vision measures stayed alike between groups, though one pupil reflex ran slower with atropine. The authors conclude the pairing is effective and safe over two years.

Catalog record

CREATORYing Yuan, Yuqi Deng, Chengcheng Zhu, Xinting Liu, Wei Zhang, Bingru Zheng, Xinjie Mao, Xiao Yang, Bilian Ke
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13171514

Browse the full library · About the Tower of Babel